HOME >> BIOLOGY >> NEWS
JCI table of contents, February 2, 2004

1. Understanding the autoimmune response in type 1 diabetes

Type 1 diabetes mellitus (T1DM) is the result of immune-mediated destruction of insulin-secreting pancreatic beta cells. For more than 25 years researchers have searched for an environmental agent or event that triggers this autoimmune response. Past research has suggested that T cells that react to islet beta cells can contribute to the autoimmune response in diabetic patients and also play a part in self-tolerance in healthy individuals. The rarity of these cells and inadequate technology has impaired the examination of this paradigm. In the February 2 issue of the Journal of Clinical Investigation Mark Peakman and colleagues from King's College London suggest a mechanism for the specificity of this immune regulation that explains why the same peptides present on pancreatic b cells that activate T cells in patients with T1DM and normal individuals cause an autoimmune response in diabetic patients, but no such response in normal individuals.

The authors developed a novel assay to examine T cell responses to a panel of epitopes naturally expressed by islet cells and demonstrated that it is the pathways of T cell differentiation and maturation in reaction to these epitopes in T1DM patients (in whom autoimmunity develops) and normal individuals (in whom autoimmunity is arrested) that are different. Upon exposure to antigen, nave T cells in normal individuals differentiate into T cells that produce IL-10, and possibly TGF- beta, subsequently inhibiting cells that would normally mediate an aggressive immune response. The results reported by Peakman and colleagues suggest that in patients with T1DM, there is instead induction of a predominant number of T cells that produce IFN-gamma and IL-2, which drives an autoaggressive immune response. Why these T cell activation pathways differ between normal and T1DM patients will require further characterization.

In an accompanying commentar
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
2-Feb-2004


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
3. JCI table of contents September 15, 2004
4. JCI table of contents: 1 September, 2004
5. Anti-cancer compound in vegetables found to block late-stage breast-cancer cell growth
6. JCI table of contents, 16 August, 2004
7. JCI table of contents, 2 August, 2004
8. When male fish hum, females swim in, thanks to hormones, adaptable hearing
9. JCI table of contents, 1 July 2004
10. Search and destroy protein turns tables on HIV
11. JCI table of contents, 15 June 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/16/2019)... , ... April 16, 2019 , ... ... 50 Healthcare Technology CEOs of 2019 . An extensive process was run to ... medical devices, biotech, healthcare analytics, healthcare software and other related areas. We gathered ...
(Date:4/12/2019)... ... April 12, 2019 , ... Gnubiotics Sciences SA ... accessible carbohydrates (MACs) as specialty ingredients for the global animal and human nutrition ... commercial launch of its first-in class microbiome modulating prebiotic GNU100, for companion animal ...
(Date:4/4/2019)... ... 02, 2019 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it will host a roundtable session at the ... Oxon Hill, Maryland, on April 10-12, 2019. , On Thursday, April 11 at ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... ... April 15, 2019 , ... Sirrus, Inc., a ... million bench plant expansion to increase production of methylene malonate monomers and oligomers. ... construction of Sirrus’ full-scale production facility, which is scheduled to break ground in ...
(Date:4/9/2019)... POWAY, Calif. (PRWEB) , ... April 09, 2019 , ... ... on his left front limb for approximately two months. After a series of ... digital flexor tendon. Sonny’s owner, Alison, researched the injury and found that ...
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. ... releasing it’s latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests ... homage to Rosland Franklin, an English chemist and X-ray crystallographer who made significant ...
(Date:3/27/2019)... , ... March 27, 2019 , ... Lachman is sponsoring ... the Clayton Hotel Burlington Road, Dublin, Ireland. The executive team on site will be ... 4.0, two key tracks on the agenda this year. , Executives from Lachman participating ...
Breaking Biology Technology:
Cached News: